Three important immunomodulators (CXCL10, CXCL11, and CCR1) were affirmatively associated with expression of CMTM6 within PAAD in a significant manner, which played an important role in inducing the CD8+ T-cell recruitment to the TME. This evidence concerns the gene CXCL10 and pancreatic adenocarcinoma.